No Data
No Data
No Data
No Data
No Data
Analysts Offer Insights on Healthcare Companies: Viking Therapeutics (VKTX), Acrivon Therapeutics, Inc. (ACRV) and Gain Therapeutics (GANX)
TipRanks06:30 ET
Gain Therapeutics Shares Rise 8% After Positive Results From Early Trial of Parkinson's Disease Therapy
By Chris Wack Gain Therapeutics shares rose after the company said it saw positive results from an early study of its potential Parkinson's Disease therapy. Shares were up 8% to $3.65 in early tradi
WSJApr 24 09:53 ET
Express News | Gain Therapeutics Announces Positive Results From the Single Ascending Dose (Sad) Part of the Phase 1 Clinical Trial of GT-02287, a Novel Gcase-Targeting Small Molecule Therapy for Gba1 Parkinson’s Disease
Moomoo 24/7Apr 24 09:25 ET
Express News | Oppenheimer Maintains Outperform on Gain Therapeutics, Maintains $9 Price Target
Moomoo 24/7Apr 23 08:21 ET
Oppenheimer Remains a Buy on Gain Therapeutics (GANX)
TipRanksApr 23 07:45 ET
Here's Why Gain Therapeutics (GANX) Could Be Great Choice for a Bottom Fisher
Yahoo FinanceApr 17 09:55 ET
No Data
No Data